Dexamethasone vs. Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial
Journal of Clinical Medicine · 11.06.2026 · 15 (12) · 4513
DOI: 10.3390/jcm15124513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2026. Verfasst von Ewa Grelowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, Poznan University of Medical Sciences, ul. Długa 1/2, 61-848 Poznan, Poland. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Total knee arthroplasty is associated with significant postoperative pain. The erector spinae plane block (ESPB) is increasingly used as part of multimodal analgesia, but its duration may be limited. Adjuvants such as dexamethasone and dexmedetomidine may enhance analgesic efficacy; however, direct comparisons between these agents in ESPB remain limited.
Methods
In this prospective, randomized, double-blind trial, 90 patients undergoing total knee arthroplasty were allocated to receive ESPB with ropivacaine alone (control), with ropivacaine plus dexamethasone (DEX), or with ropivacaine plus dexmedetomidine (DEM) (n = 30 per group). The primary outcome was time-to-first opioid requirement within 48 h. Secondary outcomes included total opioid consumption, postoperative pain intensity (NRS), and adverse events. Time-to-event analysis was performed using Kaplan–Meier and Cox regression.
Results
Time-to-first opioid requirement was significantly prolonged in both DEX and DEM groups compared with control (log-rank p < 0.0001). Median time was 7.85 h (95% CI 7.40–8.50) in control, 13.70 h (12.80–14.50) in DEX, and 12.40 h (11.20–14.30) in DEM. Both DEX (HR 0.036, 95% CI 0.017–0.079) and DEM (HR 0.058, 95% CI 0.028–0.121) significantly reduced the hazard of opioid requirement (p < 0.0001). Total opioid consumption was significantly lower in the DEX group compared with both control and DEM (p < 0.0001), while no difference was observed between DEM and control. Pain scores were lower in the DEX group in the early postoperative period. No statistically significant differences in adverse events were observed between groups.
Conclusions
Both dexamethasone and dexmedetomidine prolong ESPB analgesia in total knee arthroplasty. However, dexamethasone provides superior analgesic efficacy without increasing adverse events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, Poznan University of Medical Sciences, ul. Długa 1/2, 61-848 Poznan, Poland.
- Pathophysiology of Pain Unit, Department of Anesthesiology and Intensive Care, Poznan University of Medical Sciences, ul. Przybyszewskiego 49, 60-355 Poznan, Poland.
- Department of Pediatric Anesthesiology and Intensive Care, Poznan University of Medical Sciences, ul. Szpitalna 27/33, 60-572 Poznan, Poland.
- Department of Clinical Anesthesiology and Pain Management, Poznan University of Medical Sciences, ul. 28 Czerwca 1956 135/147, 61-701 Poznan, Poland.
- Department of Palliative Medicine, Poznan University of Medical Sciences, ul. Os. Rusa 55, 61-245 Poznan, Poland.
- Department of Pathophysiology of Locomotor Organs, Wiktor Dega Orthopedic Institute, Poznan University of Medical Sciences, ul. 28 Czerwca 1956 r. 135/147, 61-545 Poznan, Poland.
ORCID-Profile: Tomasz Reysner, Jowita Rosada-Kurasińska, Paweł Pietraszek, Anna Perek, Aleksandra Łakomy, Malgorzata Reysner
Zitieren
APA
Grelowska, E., Reysner, T., Rosada-Kurasińska, J., Marszałek-Buko, J., Pietraszek, P., Perek, A., Łakomy, A., Wieczorowska-Tobis, K., Daroszewski, P., & Reysner, M. (2026). Dexamethasone vs. Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial. Journal of Clinical Medicine, 15(12), 4513. https://doi.org/10.3390/jcm15124513
Vancouver
Grelowska E, Reysner T, Rosada-Kurasińska J, Marszałek-Buko J, Pietraszek P, Perek A, et al. Dexamethasone vs. Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial. Journal of Clinical Medicine. 2026;15(12):4513. doi:10.3390/jcm15124513
BibTeX
@article{Grelowska2026,
author = {Grelowska, Ewa and Reysner, Tomasz and Rosada-Kurasińska, Jowita and Marszałek-Buko, Justyna and Pietraszek, Paweł and Perek, Anna and Łakomy, Aleksandra and Wieczorowska-Tobis, Katarzyna and Daroszewski, Przemysław and Reysner, Malgorzata},
title = {Dexamethasone vs. Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4513},
doi = {10.3390/jcm15124513}
}
EUVIMED